Public health officials in Saint Lucia have issued an urgent safety advisory urging residents to exercise extreme caution when accessing prescription medications, particularly in-demand GLP-1 products such as Ozempic, a drug approved both for type 2 diabetes management and clinical weight regulation.
Speaking on behalf of the Ministry of Health, Wellness and Nutrition, Chief Pharmacist Astrid Mondesir outlined growing official anxiety over rising reports of unlicensed vendors, including unregistered pharmacies, marketing and selling GLP-1 treatments and their compounded alternatives directly to consumers.
“We understand that countless people are actively searching for evidence-based treatments to boost their physical health and overall quality of life,” Mondesir noted. “But sourcing any prescription medication from unapproved channels exposes buyers to severe, avoidable health hazards. These risks include receiving counterfeit formulations, contaminated doses, improperly stored products, expired medications, or incorrectly prepared compounded versions that do not meet clinical safety standards.”
Health authorities are reinforcing a core public health message: all prescription medications must only be used under the direct supervision of a qualified physician or other legally authorized prescriber. Prior to starting any new prescription treatment, patients must complete a full medical evaluation to confirm that the therapy is safe, effective, and tailored to their specific health condition and needs.
Under Saint Lucia’s existing Pharmacy Act CAP 11.21, patients are required to consult a licensed medical provider before initiating any GLP-1-based treatment, and may only obtain their prescription from state-registered pharmacies. The ministry specifically warned against purchasing GLP-1 or other prescription drugs from unlicensed street sellers, retail beauty shops, social media platforms, and any other outlet not formally authorized to distribute prescription medications.
The Ministry’s core goal in issuing this advisory is to protect patient safety and guarantee that all local residents can access consistent, high-quality, clinically tested medications that meet national safety standards.
Mondesir summed up the ministry’s key guidance for residents considering GLP-1 treatment: “The single most critical step to protect your health is to speak with your personal physician first, and only obtain your medication through a registered, licensed pharmacy.”
Going forward, the Ministry of Health reaffirmed its commitment to ongoing regulatory work that guarantees all people in Saint Lucia have access to safe, effective, tightly regulated healthcare services and pharmaceutical products.